analyse outcomes and safety of open, laparoscopic and robotic simple prostatectomy.
INTRODUCTION AND OBJECTIVES: Surgeries for benign prostatic hyperplasia (BPH) are commonly performed by urologists worldwide. Durability of these surgeries is reflected by the need for repeat endoscopic surgery. While clinical trials offer insight into short and intermediate-term reoperation in a controlled setting, long-term retreatment rates in the real world are not well characterized. This study compared reoperation rates following various surgical modalities for BPH treatment.
METHODS: A retrospective single health system database was used to identify patients undergoing a first-time surgery for BPH, including transurethral resection of the prostate (TURP), laser vaporization of the prostate (LVP), and simple prostatectomy (SP). The primary outcome was endoscopic reoperation at least 90 days after the index surgery.
RESULTS: A total 4,985 patients underwent BPH surgery between 2001-2016, including 2,304 (46.2%) TURP, 2,549 (51.1%) LVP, and 132 (2.7%) SP. Median follow-up was 26.5 (IQR 7.1-59.0) months. Overall, 419 (8.4%) patients required a subsequent endoscopic operation, occurring a median 19.5 3) months after initial BPH surgery. Significant differences in reoperation rates existed across surgical modalities, with the highest reoperation rate after LVP (268/ 2549, 10.5%), followed by TURP (148/2304, 6.4%), and lowest rate of subsequent endoscopic surgery after SP (3/132, 2.3%) (p<0.0001). On Cox proportional hazards regression analysis adjusting for baseline demographic and clinical characteristics, primary BPH surgical modality was independently associated with subsequent endoscopic surgery (p[0.007). Compared to LVP (referent), TURP (hazard ratio [HR] 0.78, 95% confidence interval 0.64-0.95) and SP (HR 0.28, 0.09-0.87) were less likely to require secondary surgery (Figure 1) .
CONCLUSIONS: Variation exists in rates of subsequent endoscopic surgery following surgical treatment of BPH, suggesting specific approaches provide differing long-term durability. Reoperations reflect increased patient morbidity and greater healthcare resource utilization. Discrepant reoperation rates should be factored into the shared decision-making process for BPH management.
Source of Funding: None

MP01-12 A SYSTEMATIC REVIEW AND META-ANALYSIS EVALUATING THE SAFETY AND EFFICACY OF THE ENDOSCOPIC TREATMENT OPTIONS FOR BENIGN PROSTATIC ENLARGEMENT.
assessed by: a) perioperative data, including tissue volume removed, operation time (OT), catheterization time and hospital length of stay (LOS), and b) functional outcomes, which evaluate International Prostate Symptom Score (IPSS), IEFF-5, maximum flow rate (Qmax), postvoid residual volume (PVR) and quality of life (QoL). The technique safety was assessed by complications, Hb and sodium decrease and transfusion rate. Meta-analyses were performed using the RevManÒ 5.3 software.
RESULTS: Out of the 35 RCTs (4066 patients) comparing different techniques for BPE treatment, 32 studies (3819 patients) evaluated EEP versus ENE and 3 RCTs (247 patients) evaluated L-EEP versus NL-EEP methods. Comparing EEP vs ENE, the first was associated with greater Qmax after short and long-term follow-up (F/U). EEP was associated with shorter catheterization time, hospital LOS, and lesser Hb decrease and transfusion rate. OT and bladder injury were greater in the EEP group There were no significant differences between other evaluated items. Comparing EEP techniques, L-EEP group were associated with shorter OT and more tissue volume removed. There were no significant differences in others perioperative data, functional outcomes and complications comparisons between groups.
CONCLUSIONS: Endoscopic treatments for BPH has similar efficacy. EEP appear to be safe and is related with: lesser Hb decrease, lesser transfusion rate and increased bladder injury rate comparing to ENE. Comparing with NL-EEP, L-EEP provides a greater tissue removal and a shorter OT, with the same safety and functional profiles.
Source of Funding: none
MP01-13 A HIGH PREOPERATIVE PSA LEVEL IS NOT ACCURATE TO PREDICT INCIDENTAL PROSTATE CANCER DETECTION IN PATIENT UNDERWENT ENDOSCOPIC ENUCLEATION OF THE PROSTATE FOR LARGE GLANDS.
Vincent Misrai*, Toulouse, France; Benoit Peyronnet, Rennes, France; Benjamin Pradere, Tours, France; Benoit Bordier, Julien Guillotreau, Alexandre Gryn, Toulouse, France; Kevin C. Zorn, Montreal, Canada INTRODUCTION AND OBJECTIVES: Incidental prostate cancer (IPCa) detection is estimated between 6 and 12% on open prostatectomy or morcellation sample chips analysis. High preoperative PSA level has been identified as a potential predictive factor. However, a significant increase in the value of PSA is frequently observed in large glands.
The objective was to evaluate the accuracy of high preoperative PSA level for IPCa detection in patients underwent endoscopic enucleation of the prostate (EEP) for large glands.
METHODS: Perioperative data from 308 consecutive patients underwent EEP for benign prostatic obstruction between July 2013 and December 2017 were collected prospectively and gathered in 3 groups according to preoperative PSA level: LOW-PSA (<4ng/mL), INTERMEDIATE-PSA (4 PSA <10ng/mL) and HIGH-PSA (!10ng/ mL). Patients were matched in each group based on propensity score according to age, the use of 5alpha-reductase inhibitors and the prostatic volume (Figure 1) . The detection rate of IPCa was compared between 3 groups. RESULTS: Patient characteristics were similar between groups in terms of age, prostate volume and I-5AR use. The PSA density was significantly higher in HIGH-PSA group (p <0.0001). The median prostatic volume was greater than 100 grams in the 3 groups. The overall IPCa rate was similar between the 3 groups with no difference in tumor stage and Gleason score (Table 1 ). The rate of clinically significant IPCa was significant when preoperative PSA was above 4ng/mL (9.1% vs 0%) without any difference between INTERMEDIATE and HIGH-PSA groups. PSA decrease significantly from baseline in all groups, but PSA drop was greater in HIGH-PSA group.
CONCLUSIONS: In this series, overall IPCa detection was similar regardless of the preoperative PSA level. Although the rate of clinically significant IPCa was substantial for PSA> 4 ng/mL, IPCa did not increase for PSA !10ng/mL.
Source of Funding: None
MP01-14 THE SURGICAL LEARNING CURVE FOR GREEN LIGHT ENDOSCOPIC ENUCLEATION OF THE PROSTATE: IMPACT OF SURGICAL EXPERIENCE ON PERIOPERATIVE OUTCOMES
Zine-Eddine Khene*, Benoit Peyronnet, S ebastien Vincendeau, Romain Huet, Romain Mathieu, Rennes, France; Enrique Enrique, Barcelona, Spain; Fernando Gomez-Sancha, Madrid, Spain; Vincent Misrai, Toulouse, France INTRODUCTION AND OBJECTIVES: The number of cases needed to become proficient in Green Light endoscopic enucleation of the prostate (GreenLEP) is the subject of continuous debate. The aim of this study was to investigate the effect of surgical experience (EXP) on perioperative parameters to estimate the learning curve for GreenLEP.
METHODS: The cohort study included 922 patients with lower urinary tract symptoms due to BPO and treated with GreenLEP by experts' surgeons from four European institutions between 2013 and 2018. For each patient, surgeon experience was coded as the total number of procedures performed by surgeons before the patient's operation. Multivariable models were used to assess the association between surgeon experience and total operative time (OT), occurrence of intraoperative complications (IOC) and Pentafecta achievement with adjustment for established predictors.
RESULTS: Median OT was 64 min. The rate of IOC and Pentafecta achievement was 5% and 64%, respectively. At multivariable regression analyses adjusted for case mix, EXP resulted associated with shorter OT (p < 0.0001), lower intraoperative complications rate (p [ 0.001) and higher probability of pentafecta achievement (p [ 0.001). The relationship between EXP and OT/IOC appeared as nonlinear, with a steep slope reduction within the first 100 cases and a plateau observed after 200 cases. Conversely, the relationship between EXP and Pentafecta achivement resulted linear, with reaching a plateau phase at the 270 cases.
CONCLUSIONS: Increasing surgical experience is associated with substantial improvement in perioperative outcomes after Green-LEP. After 200 cases, no further improvement is observed with respect to OT and the occurrence of intraoperative complications, but the learning curve appears continue with respect to Pentafecta achievement until the 270 cases.
